Latest Daily News

More Stories

June 4, 2018

Adding 6 months of low-dose maintenance chemotherapy after standard intensive therapy improves survival in children with high-risk rhabdomyosarcoma.

Read more

June 4, 2018

Adding 6 months of low-dose maintenance chemotherapy after standard intensive therapy improves survival in children with high-risk rhabdomyosarcoma.

Read more

June 3, 2018

Radiation therapy (RT) is a well-known risk factor for subsequent malignant neoplasms (SMNs) among pediatric patients with cancer.

Read more

June 3, 2018

On June 4, Gregory H. Reaman, MD, FASCO, professor of pediatrics at George Washington University School of Medicine and Health Sciences, will receive the Pediatric Oncology Award for his outstanding leadership and achievements in the field.

Read more

June 3, 2018

ASCO’s Partners in Progress Award, to be presented June 4, honors an individual whose patient advocacy has impacted public awareness about cancer or resulted in additional support—either legislatively or fiscally—for cancer research, treatment, prevention, or care.

Read more
June 2, 2017

Dr. Michael P. Link is the recipient of the 2017 Pediatric Oncology Award in recognition of his dedication to advancing the field of pediatric oncology by finding new strategies in the management of common childhood cancers. 

Read more
June 2, 2017

Dr. Susan L. Weiner founder and director of the Children’s Cause for Cancer Advocacy and long-time pediatric brain cancer advocate, is the recipient of the 2017 Partners in Progress Award. 

Read more

May 25, 2017

A key question that remains unanswered is whether interventions that prevent or reduce risk for severe, disabling, life-threatening, or fatal chronic conditions will mitigate mortality risks for children with cancer.

Read more
June 7, 2016

Intensification of myeloablative therapy with tandem autologous stem cell transplant (ASCT) improved the probability of survival in patients with high-risk neuroblastoma, with no increase in toxicity, according to a Late Breaking Abstract (LBA3).

Read more
June 7, 2016

Patients with neuroblastoma showed encouraging response to immunotherapy with an anti-GD2 antibody, but addition of subcutaneous interleukin-2 resulted in increased toxicity with no apparent benefit. 

Read more

May 26, 2016

Susan L. Cohn, MD, a pediatric oncologist at the University of Chicago, is the 2016 recipient of the Pediatric Oncology Award. She is being recognized for her research on neuroblastoma and her leadership role in bringing together scientists worldwide to share their knowledge and expertise.

Read more

May 26, 2016

Cancer affects everyone, and the impact of the disease extends beyond the patient to those close to them. Himself a cancer survivor, Chicago Cubs first baseman Anthony Rizzo founded the Anthony Rizzo Family Foundation to raise money to support families fighting cancer and for cancer research.

Read more
May 31, 2015

Whereas the ties between a cancer diagnosis and financial toxicity are well established, for the first time a correlation has been made between severe financial distress and increased early mortality in patients with cancer.

Read more
May 31, 2015

The randomized phase III TOAD trial investigated whether immediate intervention with androgen deprivation therapy would improve overall survival compared with delayed androgen deprivation therapy in patients with prostate cancer.

Read more
May 31, 2015

LBA2: Efforts to reduce late effects of pediatric cancer treatments have reduced late mortality in those diagnosed more recently, according to new data from the Childhood Cancer Survivor Study. Deaths due to second malignant neoplasms, cardiac toxicity, and other issues have decreased.

Read more